[Falls from heights in Pediatrics. Epidemiology and evolution of 54 patients]

E Pérez-Suárez1, R Jiménez-García, M Iglesias-Bouzas

  • 1Servicio de Cuidados Intensivos Pediátricos, Hospital Infantil Universitario Niño Jesús, Madrid, España. eperez221981@hotmail.com

Medicina Intensiva
|October 22, 2011
PubMed

Insights

Falls from heights are a significant cause of child injury and death. Most survivors regain independence, but prevention in at-risk groups is crucial.

Area of Science:

  • Pediatric Traumatology
  • Injury Prevention
  • Public Health

Context:

  • Falls from heights represent a major, yet preventable, cause of child morbidity and mortality.
  • Understanding the epidemiology and risk factors is essential for targeted interventions.

Purpose:

  • To describe the outcomes and long-term prognosis of pediatric patients who fall from heights.
  • To identify high-risk pediatric populations and predictive factors for mortality upon admission.

Summary:

  • A retrospective review of pediatric intensive care unit patients who fell from over two meters was conducted over 10 years.
  • Key findings include falls from buildings, high incidence in preschoolers, and suicide attempts in adolescents. Predictors of mortality included fall height, Glasgow Coma Scale, Pediatric Trauma Index, anemia, acidosis, hypotension, vasoactive drug use, and intracranial hypertension.
  • The mortality rate was 12%, with 82% of survivors leading independent lives after two years.

Impact:

  • This study highlights the severe consequences of falls from heights in children, emphasizing the need for enhanced preventive strategies.
  • Identifying at-risk populations and predictive mortality factors can guide clinical management and resource allocation.
  • Long-term follow-up data indicate a favorable prognosis for most survivors, underscoring the importance of early and effective treatment.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...